Business Daily Media

Business Marketing

.

Hua Medicine Announces Acceptance of a New Drug Application for Dorzagliatin in China - First Glucokinase Activator (GKA) Globally

  • Written by ACN Newswire - Press Releases

Hua Medicine Announces Acceptance of a New Drug Application for Dorzagliatin in China - First Glucokinase Activator (GKA) Globally

SHANGHAI, CHINA, Apr 23, 2021 - (ACN Newswire) - Hua Medicine (the "Company", Stock Code: 2552.HK), today announced that the New Drug Application (NDA) for dorzagliatin for the treatment of Type 2 Diabetes (T2D) was accepted by the China National Medical Products Administration (NMPA). Dorzagliatin is the first glucokinase activator (GKA) to...

Popular

Crayon recognized as the Winner of 2021 Microsoft Philippines Partner of the Year Award

[Manila, Philippines] — July 8, 2021 — Crayon, a global leader in IT services and innovation, today announced it has won the Philippines 2021 Microsoft Partner of the Year Award. The company was honored among a global field ...

Jennifer Westacott speech to the Department of Foreign Affairs and Trade

After the pandemic, the risk is Australia adopts a mission accomplished mindset – failing to confront the significant challenges ahead of us over the next two decades. To meet these challenges, we’ll need to act differently...

The role of kindness in building high-performing teams 

High performing teams intrinsically have a spark that allows them to work in an effective and efficient manner. It is what leaders all around the world spend years chasing by galvanising their teams through various strategies ...

Virtual Office
Tomorrow Business Growth